An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia

Psychiatry Research

Volumn 38, Issue 2, 1991, Pages 125-134

  Häfner, Heinz ^a   Behrens, Stephan ^b   De Vry, Jean ^a   Gattaz, Wagner F ^c  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b Stpehan Behrens ^*  (Germany)

^c MEDA Manufacturing GmbH   (Germany)

Author keywords

estradiol; Schizophrenia; sex differences; testosterone

Indexed keywords

APOMORPHINE; DOPAMINE; ESTRADIOL; HALOPERIDOL; SULPIRIDE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; FEMALE; MALE; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SEX; SUBCUTANEOUS DRUG ADMINISTRATION;

AGE FACTORS; ANIMAL; APOMORPHINE; CATALEPSY; ESTRADIOL; FEMALE; HALOPERIDOL; MALE; RATS; RECEPTORS, DOPAMINE; SCHIZOPHRENIA; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; TESTOSTERONE;

EID: 0025779205     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(91)90038-Q     Document Type: Article

References (40)

1. Gender differences in age at onset of schizophrenia: An overview
2. Pharmacological specifity of conditioned avoidance response inhibition in rats: Inhibition by neuroleptics and correlation to dopamine receptor blockade
3. Stereotyped behavior elicited by amphetamine in the rat: Influences of the testes
4. Oestrogens and extrapyramidal system
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. The dopamine hypothesis of schizophrenia 20 years later
7. Psychosis and pregnancy
8. Menstruation and acute psychiatric illness
9. Modulation of brain and pituitary dopamine receptors by estrogens and prolactin
10. Effect of prolactin and estradiol on rat striated dopamine receptors
11. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
12. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics
13. Structural brain abnormalities in schizophrenia: An integrative model
14. Dopamine and noradrenalin in the cerebrospinal fluid of schizophrenic patients
15. Epidemiology of schizophrenia
16. New perspectives in the epidemiology of schizophrenia
17. How does gender influence age at first hospitalization for schizophrenia? A transnational case reporter study
18. Über das Zusammenwirken von Östradiol und Dopamin bei der Verhaltenssteuerung von Säugern
19. Animal models in psychiatry
20. Elevation of striatal dopamine receptors by estrogen: Dose and time studies
21. 3H]-sulpiride binding sites in rat striatal membranes
22. Premenstrualmenstrual increases in psychiatric admission rates
23. Epidemiology of puerpural psychoses
24. The adenohypophyseal dopamine receptors, specificity and modulation of its activity by estradiol
25. Gender and schizophrenia
26. Acute psychiatric admission related to the menstrual cycle
27. Differential effects of estrogen and androgen on locomotoractivity induced in castrated male rats by amphetamine or apomorphine
28. Psychiatric illness following childbirth in Southhampton: A case register study
29. Potent antidopaminergic activity of estradiol at the pituitary level of prolactin release
30. Schizophrenia—A disease of young single males? Preliminary results from an investigation on a representive cohort admitted to hospital for the first time
31. Graphic method for the determination and presentation of binding parameters in a complex system
32. Prognostic implications of the sex of schizophrenic patients
33. Validity of diagnostic concepts across cultures
34. Interaction of sex, age and neuroleptic dose
35. The role of estrogens in schizophrenia gender differences
36. Extrapyramidal syndromes and other neurological side effects of psychotropic drugs
37. A different look at measurement and interpretation of drug induced stereotyped behavior
38. 2 receptors in rat striatal membranes: Methodological considerations and demonstration of the identinature of the binding sites for the two ligands
39. Estrogens in tardive dyskinesia in male psychiatric patients
40. The relationship of demographic, clinical, and outcome variables to neuroleptic treatment requirements